Overview
Over 100 chronic conditions, including celiac disease, have been associated with increased levels of Anti-Gliadin antibody (gliadin is the protein component of gluten). Since the 1970’s, gluten-free diets have shown to be a reliable treatment in allowing celiac patients to return to “normalcy”.
Recent research has shown the detection of Anti-Gliadin IgG and IgA to be an indicator of gliadin involvement in the medical condition. The test detects both IgG and IgA to gliadin by the ELISA method. This test is a very effective screening test for gliadin and is a good method for monitoring patients’ adherence to a gluten-free diet.